Related Experiment Video
Updated: Dec 24, 2025

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice
Published on: September 17, 2015
Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV)
Jun-Won Lee1, Eunhee Choi2, Jung-Woo Son1
1Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.
Insights
Amlodipine and losartan showed similar effects on systolic blood pressure variability (BPV). However, amlodipine may be more effective in reducing overall BPV in essential hypertension patients.
Area of Science:
- Cardiology
- Pharmacology
- Hypertension Management
Background:
- Established antihypertensive therapies using renin-angiotensin system blockers and calcium channel blockers do not yet have a defined strategy for targeting blood pressure variability (BPV).
- Essential hypertensive patients require comparative studies on the efficacy of different antihypertensive agents in managing BPV.
Purpose of the Study:
- To compare the efficacy of losartan (a renin-angiotensin system blocker) and amlodipine (a calcium channel blocker) in reducing blood pressure variability (BPV) and systolic blood pressure (SBP).
Main Methods:
- A randomized trial involving essential hypertensive patients assigned to either losartan 50 mg or amlodipine 5 mg.
- Medications were uptitrated, with hydrochlorothiazide added as needed over a 6-month period.
- Primary endpoint: office visit-to-visit standard deviation (SD) of SBP; Secondary endpoints: average real variability (ARV), office SBP, and home SBP.
Main Results:
- The office visit-to-visit SD of SBP was comparable between the losartan and amlodipine groups.
- The losartan group exhibited significantly higher office visit-to-visit ARV of SBP and evening day-to-day home BPV indexes.
- While absolute SBP reduction was similar, office mean SBP at 6 months was higher in the losartan group.
Conclusions:
- Both losartan and amlodipine demonstrated similar effects on reducing office visit-to-visit SD of SBP.
- Amlodipine may offer superior BPV reduction compared to losartan, as indicated by higher ARV and home BPV indexes in the losartan group.
- Amlodipine could be a preferred choice for managing BPV in essential hypertensive patients.
Background:
Antihypertensive therapy using renin-angiotensin system blockers and calcium channel blockers to target blood pressure variability (BPV) has not yet been established. We aimed to compare the ability of losartan and amlodipine to lower BPV and systolic blood pressure (SBP) in essential hypertensive patients.
Methods:
Patients were randomly assigned either losartan 50 mg or amlodipine 5 mg. Medications were uptitrated and hydrochlorothiazide was added according to protocol for 6 months. The primary endpoint was the office visit-to-visit SD of SBP. The secondary endpoints included average real variability (ARV), office SBP, and home SBP.
Results:
The losartan group (n = 71) and amlodipine group (n = 73) finished the scheduled visits between April 2013 and May 2017. The office visit-to-visit SD of SBP was comparable between the losartan and amlodipine groups (11.0 ± 4.2 vs. 10.5 ± 3.8, P = 0.468). The office visit-to-visit ARV of SBP was significantly elevated in the losartan group (10.6 ± 4.3 vs. 9.1 ± 3.4, P = 0.02). The absolute SBP decrement from baseline to 6 months was similar between groups, although the office mean SBP at 6 months was higher in the losartan group (132.3 ± 12.9 vs. 127.5 ± 9.0 mm Hg, P = 0.011). In home blood pressure analysis, evening day-to-day BPV indexes (SD and ARV) were significantly higher in the losartan group at 6 months.
Conclusions:
The lowering effect of the office visit-to-visit SD of SBP was similar between losartan and amlodipine. However, the losartan group showed a higher office visit-to-visit ARV of SBP and evening day-to-day home BPV indexes. Therefore, amlodipine may be better to lower BPV in essential hypertensive patients.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension and Regulation of Blood Pressure
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension IV: Drug Therapy and Lifestyle Modifications

